Datavault AI Inc. (NASDAQ: DVLT) announced the expansion of its definitive licensing agreement with DataMeds AI Inc. (NASDAQ: MEDS) to extend its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan and wellness applications. The amended agreement is designed to support patient-controlled health data access, monetization and real-world asset tokenization across pharmacy, medical, laboratory and wearable device environments, leveraging a behavioral healthcare patent portfolio focused on medical logistics, IoT population health and AI-driven remote patient monitoring.
Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies said the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
The expanded partnership underscores the growing intersection of blockchain, AI and healthcare data management. By allowing patients to control and monetize their own health data, the companies aim to address privacy concerns and create new economic models for health information. The technology also supports tokenization of real-world assets, which could transform how medical records, lab results and wearable device data are valued and exchanged.
Datavault AI, headquartered in Philadelphia, PA, is a leader in AI-driven data experiences, valuation and monetization in the Web 3.0 environment. Its cloud-based platform provides solutions through Acoustic Sciences and Data Sciences divisions. The Acoustic Sciences division features patented WiSA, ADIO and Sumerian technologies for spatial and multichannel wireless high-definition sound transmission. The Data Science division leverages Web 3.0 and high-performance computing for data perception, valuation and secure monetization.
The company’s platform serves multiple industries, including sports and entertainment, biotech, education, fintech, real estate, healthcare and energy. Its Information Data Exchange enables Digital Twins and licensing of name, image and likeness by securely attaching physical objects to immutable metadata. The technology suite offers AI and machine learning automation, third-party integration and detailed analytics.
For more information, see the full press release at https://ibn.fm/vBAxH and visit Datavault AI’s website at https://dvlt.ai.
